miR-150 regulates the development of NK and iNKT cells

被引:188
作者
Bezman, Natalie A. [1 ,2 ]
Chakraborty, Tirtha [3 ,4 ]
Bender, Timothy [5 ]
Lanier, Lewis L. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[3] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[5] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA
基金
美国国家卫生研究院;
关键词
NATURAL-KILLER-CELLS; RECEPTOR-GAMMA-CHAIN; FACTOR C-MYB; MHC CLASS-I; TRANSCRIPTION FACTOR; T-CELL; B-CELL; GENE-EXPRESSION; INHIBITORY RECEPTORS; LY49; RECEPTORS;
D O I
10.1084/jem.20111386
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) and invariant NK T (iNKT) cells are critical in host defense against pathogens and for the initiation of adaptive immune responses. miRNAs play important roles in NK and iNKT cell development, maturation, and function, but the roles of specific miRNAs are unclear. We show that modulation of miR-150 expression levels has a differential effect on NK and iNKT cell development. Mice with a targeted deletion of miR-150 have an impaired, cell lineage-intrinsic defect in their ability to generate mature NK cells. Conversely, a gain-of-function miR-150 transgene promotes the development of NK cells, which display a more mature phenotype and are more responsive to activation. In contrast, overexpression of miR-150 results in a substantial reduction of iNKT cells in the thymus and in the peripheral lymphoid organs. The transcription factor c-Myb has been shown to be a direct target of miR-150. Our finding of increased NK cell and decreased iNKT cell frequencies in Myb heterozygous bone marrow chimeras suggests that miR-150 differentially controls the development of NK and iNKT cell lineages by targeting c-Myb.
引用
收藏
页码:2717 / 2731
页数:15
相关论文
共 70 条
[1]   Human NK cell education by inhibitory receptors for MHC class I [J].
Anfossi, Nicolas ;
Andre, Pascale ;
Guia, Sophie ;
Falk, Christine S. ;
Roetynck, Sophie ;
Stewart, C. Andrew ;
Breso, Violette ;
Frassati, Coralie ;
Reviron, Denis ;
Middleton, Derek ;
Romagne, Francois ;
Ugolini, Sophie ;
Vivier, Eric .
IMMUNITY, 2006, 25 (02) :331-342
[2]   Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [J].
Arase, H ;
Mocarski, ES ;
Campbell, AE ;
Hill, AB ;
Lanier, LL .
SCIENCE, 2002, 296 (5571) :1323-1326
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   The Ets-1 transcription factor is required for the development of natural killer cells in mice [J].
Barton, K ;
Muthusamy, N ;
Fischer, C ;
Ting, CN ;
Walunas, TL ;
Lanier, LL ;
Leiden, JM .
IMMUNITY, 1998, 9 (04) :555-563
[5]   Critical functions for c-Myb at three checkpoints during thymocyte development [J].
Bender, TP ;
Kremer, CS ;
Kraus, M ;
Buch, T ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (07) :721-729
[6]   A thymic precursor to the NK T cell lineage [J].
Benlagha, K ;
Kyin, T ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
SCIENCE, 2002, 296 (5567) :553-555
[7]   Distinct Requirements of MicroRNAs in NK Cell Activation, Survival, and Function [J].
Bezman, Natalie A. ;
Cedars, Elizabeth ;
Steiner, David F. ;
Blelloch, Robert ;
Hesslein, David G. T. ;
Lanier, Lewis L. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (07) :3835-3846
[8]   Maturation of mouse NK cells is a 4-stage developmental program [J].
Chiossone, Laura ;
Chaix, Julie ;
Fuseri, Nicolas ;
Roth, Claude ;
Vivier, Eric ;
Walzer, Thierry .
BLOOD, 2009, 113 (22) :5488-5496
[9]   A role for Dicer in immune regulation [J].
Cobb, Bradley S. ;
Hertweck, Arnulf ;
Smith, James ;
O'Connor, Eric ;
Graf, Daniel ;
Cook, Terence ;
Smale, Stephen T. ;
Sakaguchi, Shimon ;
Livesey, Frederick J. ;
Fisher, Amanda G. ;
Merkenschlager, Matthias .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (11) :2519-2527
[10]  
Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO